Outcomes following HDR Brachytherapy Boost for High Risk Localised Prostate Cancer: Data from a UK Centre

被引：0
|
作者：
Lorimer, C. [1 ]
Ravi, B. [1 ]
Cowtan, F. [1 ]
Johns, A. [1 ]
Robinson, A. [1 ]
Nikapota, A. [1 ]
机构：
[1] Univ Hosp Sussex NHS Trust, Brighton, England
来源：
CLINICAL ONCOLOGY | 2023年 / 35卷 / 02期
关键词：
DOSE-RATE BRACHYTHERAPY; INTERMEDIATE; MONOTHERAPY;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：E241 / E241
页数：1
相关论文
共 50 条
  • [21] Local control is improved with HDR-boost for localised prostate cancer
    Kragelj, B.
    Grmek, M.
    RADIOTHERAPY AND ONCOLOGY, 2015, 115 : S673 - S673
  • [22] High dose rate (HDR) brachytherapy boost for prostate cancer gives high control rate
    Flynn, J. P.
    Kelly, D. A.
    Brookover, T.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2007, 69 (03): : S323 - S324
  • [23] HDR Prostate Brachytherapy Boost for T3b Cancer: The Stokes Centre for Urology Experience
    Metawe, M.
    Mehta, S.
    Uribe, S.
    Otter, S.
    Long, M.
    Langley, S.
    CLINICAL ONCOLOGY, 2022, 34 (03) : E146 - E146
  • [24] MRI-guided Ultrafocal HDR-brachytherapy for Localised Prostate Cancer
    David, John
    Kamrava, Mitchell
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 104 (05): : 1182 - 1183
  • [25] Salvage HDR brachytherapy for localised recurrent prostate cancer after primary irradiation
    Stankiewicz, M.
    Wojcieszek, P.
    Lelek, P.
    Krzysztofiak, T.
    Kellas-Sleczka, S.
    RADIOTHERAPY AND ONCOLOGY, 2021, 161 : S1096 - S1097
  • [26] Population outcomes of EBRT with LDR brachytherapy boost for intermediate, high-risk prostate cancer
    Oh, J.
    Spadinger, I.
    Lapointe, V.
    Morris, J.
    RADIOTHERAPY AND ONCOLOGY, 2020, 152 : S372 - S372
  • [27] SINGLE FRACTION HDR BRACHYTHERAPY AS ANTICIPATED BOOST IN LOCALIZED PROSTATE CANCER
    Cerrotta, A.
    Fallai, C.
    Carrara, M.
    Borroni, M.
    Villa, S.
    Bedini, N.
    Garcia, M.
    Maucione, A.
    RADIOTHERAPY AND ONCOLOGY, 2011, 99 : S288 - S289
  • [28] HDR BRACHYTHERAPY OF PROSTATE CANCER AS A BOOST AFTER EXTERNAL BEAM RADIOTHERAPY
    Kanikowski, M.
    Skowronek, J.
    Kubaszewska, M.
    Chichel, A.
    RADIOTHERAPY AND ONCOLOGY, 2008, 88 : S324 - S324
  • [29] The radiosensitivity index predicts benefit from HDR brachytherapy in high-risk prostate cancer
    Thiruthaneeswaran, N.
    Bibby, B. A. S.
    Pereira, R.
    More, E.
    Denley, H.
    Henry, A.
    Wylie, J.
    Hoskin, P.
    Bristow, R.
    Choudhury, A.
    West, C.
    RADIOTHERAPY AND ONCOLOGY, 2020, 152 : S1086 - S1087
  • [30] Pretherapeutic nomogram predicting disease recurrence following HDR- brachytherapy for high risk-prostate cancer
    Schwarz, R.
    Chun, F. K. H.
    Karakiewicz, P., I
    Gallina, A.
    Walz, J.
    Briganti, A.
    Steuber, T.
    Schlomm, T.
    Haese, A.
    Graefen, M.
    Suardi, N.
    Alberti, W.
    Huland, H.
    Kruell, A.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2008, 184 : 139 - 139
12345